Page 1493 - Clinical Small Animal Internal Medicine
P. 1493

162  Autoimmune and Immune‐Mediated Skin Diseases  1431

               alopecia areata, vitiligo, pemphigus erythematosus, and   tuted along with systemic glucocorticoids combined
  VetBooks.ir  epitheliotropic cutaneous lymphoma.                with azathioprine or ciclosporin (see Table 162.1).
                 Therapy should be directed towards preserving vision.
                                                                   Complications may include secondary glaucoma,
               Skin lesions may respond while eye lesions continue to
               progress. Frequent monitoring of the eyes is important.     cataracts, and blindness. Prognosis is guarded, although
                                                                  better when treatment is instituted early in the disease
               Topical or intravitreal glucocorticoids, topical cyclople-  course. Repigmentation of the skin and hair may or may
               gics, and carbonic anhydrase inhibitors should be insti-  not occur.


                 Further Reading


               Lehner GM, Linek M. A case of vesicular cutaneous lupus   Morris DO. Ischemic dermatopathies. Vet Clin North Am
                 erythematosus in a Border collie successfully treated   Small Anim Pract 2013; 43(1): 99–111.
                 with topical tacrolimus and nicotinamide‐tetracycline.   Oberkirchner U, Linder KE, Olivry T. Successful treatment
                 Vet Dermatol 2013; 24(6): 639–41, e159–60.         of a novel generalized variant of canine discoid lupus
               Mauldin EA, Morris DO, Brown DC, Casal ML. Exfoliative   erythematosus with oral hydroxychloroquine. Vet
                 cutaneous lupus erythematosus in German shorthaired   Dermatol 2012; 23(1): 65–70, e15–16.
                 pointer dogs: disease development, progression and   Olivry T, Linder KE. Dermatoses affecting desmosomes
                 evaluation of three immunomodulatory drugs (ciclosporin,   in animals: a mechanistic review of acantholytic
                 hydroxychloroquine, and adalimumab) in a controlled   blistering skin diseases. Vet Dermatol 2009; 20(5–6):
                 environment. Vet Dermatol 2010; 21(4): 373–82.     313–26.
   1488   1489   1490   1491   1492   1493   1494   1495   1496   1497   1498